Gainers
- Innovative Eyewear, Inc. (NASDAQ:LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
- Minim, Inc. (NASDAQ:MINM) gained 33.3% to $0.2828. Minim, during August, posted a Q2 loss of $0.10 per share.
- Top Ships Inc. (NASDAQ:TOPS) jumped 28.1% to $8.20. TOP Ships announced termination of at the market equity offering program of $19.7 million.
- Dunxin Financial Holdings Limited (NYSE:DXF) gained 22.8% to $0.33. Dunxin Financial Holdings recently posted 1H EPS of $0.35.
- First Wave BioPharma, Inc. (NASDAQ:FWBI) rose 21.6% to $1.97 as the company reported pricing of $6.0 million public offering.
- Aditxt, Inc. (NASDAQ:ADTX) shares gained 21.5% to $4.02 after the company announced AditxtScore is featured by FedEx in a video presentation.
- Aehr Test Systems (NASDAQ:AEHR) gained 19.4% to $16.54 after the company announced better-than-expected Q1 EPS and sales results and issued guidance.
- Femasys Inc. (NASDAQ:FEMY) gained 16.4% to $1.35. Femasys announced enrollment completion for Stage 2 study of FemBloc for permanent birth control.
- Plus Therapeutics, Inc. (NASDAQ:PSTV) rose 14.1% to $0.6220. JonesTrading initiated coverage on Plus Therapeutics with a Buy rating and announced a price target of $5.
- WeTrade Group, Inc. (NASDAQ:WETG) jumped 11.2% to $1.29.
- Greenlane Holdings, Inc. (NASDAQ:GNLN) gained 10.8% to $2.1950. Greenlane announced management changes in connection with transition to consumer brands business model. Craig Snyder, the company’s current President, will take the helm as CEO effective January 1,2023.
- Broadway Financial Corporation (NASDAQ:BYFC) jumped 10.7% to $1.2296.
- Ambac Financial Group, Inc (NASDAQ:AMBC) rose 9.7% to $14.03 after the company announced it settled its RMBS litigations against Bank of America for $1.84 billion.
- Abeona Therapeutics Inc. (NASDAQ:ABEO) gained 9.6% to $3.8602. Abeona Therapeutics recently announced completion of patient follow-up in pivotal Phase 3 VIITAL study of EB-101.
- Inventiva S.A. (NASDAQ:IVA) rose 8.8% to $4.5282 after gaining around 10% on Thursday.
- HEXO Corp. (NASDAQ:HEXO) rose 8.5% to $0.2323. Shares of HEXO traded higher by 17% on Thursday after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
- DexCom, Inc. (NASDAQ:DXCM) gained 8.2% to $102.98 after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $110 to $120.
- Payoneer Global Inc. (NASDAQ:PAYO) rose 8.1% to $7.64. Payoneer Global will replace Lantheus Holdings in the S&P SmallCap 600 effective on Wednesday, October 12.
- Provention Bio, Inc. (NASDAQ:PRVB) shares gained 7.5% to $6.69. Provention Bio announced it has entered into a co-promotion agreement with Sanofi U.S. for the launch of its lead investigational drug candidate teplizumab. Jefferies maintained Provention Bio with a Buy and raised the price target from $10 to $15.
- IDT Corporation (NYSE:IDT) gained 7.2% to $29.90 after the company reported Q4 EPS results up from last year.
- Atlas Corp. (NYSE:ATCO) rose 6.5% to $14.96 after Poseidon Acquisition reported it believes it has made meaningful progress in its discussions with Atlas to acquire all common shares of Atlas not controlled by consortium members.
- DraftKings Inc. (NASDAQ:DKNG) rose 4.2% to $16.69 on the buzz surrounding a large partnership with Walt Disney’s ESPN.
- Credit Suisse Group AG (NYSE:CS) rose 4% to $4.4550 after reports said the company was planning to buy back $3 billion of its debt as part of its plans to streamline following questions about its financial health.
Losers
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares dipped 58.4% to $2.62 after the company priced a roughly 3.6 million unit offering at $3.30 per unit.
- InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) fell 37.3% to $5.00 after the company announced $9 million registered direct and private placement offerings priced at-the-market under Nasdaq rules.
- Bone Biologics Corporation (NASDAQ:BBLG) shares fell 36.4% to $0.5720 after the company priced a 3,777,778 unit offering at $1.35 per unit.
- Pineapple Energy Inc. (NASDAQ:PEGY) fell 25.4% to $3.3905 after jumping around 65% on Thursday.
- Argo Blockchain plc (NASDAQ:ARBK) fell 23.7% to $3.18 after the company announced strategic actions to strengthen its balance sheet..
- Code Chain New Continent Limited (NASDAQ:CCNC) fell 23.6% to $0.1884.
- Atlis Motor Vehicles, Inc. (NASDAQ:AMV) fell 22% to $19.10 on post-IPO volatility.
- INNOVATE Corp. (NASDAQ:VATE) dipped 21.8% to $0.7120.
- PureTech Health plc (NASDAQ:PRTC) fell 21.4% to $24.34. Puretech Health confirmed that it has exchanged indicative, non-binding proposals with Nektar Therapeutics regarding a possible combination.
- Agrify Corporation (NASDAQ:AGFY) shares fell 21.1% to $0.4249. Agrify issued statement refuting lawsuit from defaulted customer Bud & Mary's Cultivation.
- Kiromic BioPharma, Inc. (NASDAQ:KRBP) dropped 20% to $0.3137. Kiromic BioPharma recently announced it received feedback from the FDA pursuant to its Type B Pre-IND meeting request regarding its Deltacel development strategy.
- WM Technology, Inc. (NASDAQ:MAPS) fell 17.8% to $2.2699.
- ThermoGenesis Holdings, Inc. (NASDAQ:THMO) fell 17.6% to $0.2430.
- Canopy Growth Corporation (NASDAQ:CGC) dipped 17% to $3.12, possibly on profit-taking after the sector rallied on Thursday following President Biden's statement on marijuana reform. Tilray also reported worse-than-expected Q1 financial results, which has also possibly weighed on the sector.
- Statera Biopharma, Inc. (NASDAQ:STAB) fell 17% to $0.1894. Statera Biopharma said it has completed Fiscal 2021 audit and filed Form 10-K.
- Tuesday Morning Corporation (NASDAQ:TUEM) dropped 17% to $0.1253.
- Akanda Corp. (NASDAQ:AKAN) fell 16.6% to $0.3451.
- SNDL Inc. (NASDAQ:SNDL) dropped 14.8% to $2.3750. Shares of several cannabis stocks traded lower, possibly on profit-taking after the sector rallied on Thursday following President Biden's statement on marijuana reform. Tilray also reported worse-than-expected Q1 financial results, which has also possibly weighed on the sector.
- Clever Leaves Holdings Inc. (NASDAQ:CLVR) tumbled 14.6% to $0.70
- BioSig Technologies, Inc. (NASDAQ:BSGM) dipped 14.1% to $0.7560. BioSig executed purchase agreement with Methodist Hospital, San Antonio and expanded customer base.
- Twist Bioscience Corporation (NASDAQ:TWST) dropped 11.5% to $34.60 after SVB Leerink maintained a Market Perform rating on the stock and lowered its price target from $50 to $45.
- Green Giant Inc. (NASDAQ:GGE) shares fell 11.2% to $1.6690 after jumping 161% on Thursday.
- Tilray Brands, Inc. (NASDAQ:TLRY) dropped 11.2% to $3.46 after the company reported worse-than-expected Q1 adjusted EPS and sales results.
- Quanergy Systems, Inc. (NYSE:QNGY) fell 9.8% to $3.3947. The company recently announced a 1-for-20 reverse stock split.
- Lithium Americas Corp. (NYSE:LAC) dropped 9.8% to $24.48. Lithium Americas confirmed oral hearing schedule for Thacker Pass record of decision appeal.
- CVS Health Corporation (NYSE:CVS) fell 9.2% to $89.46 after the company announced CMS downgraded Aetna National PPO. The decrease in the Star Rating for the Aetna National PPO will mean that it will no longer be eligible for CMS' quality bonus payments related to 2024.
- Advanced Micro Devices, Inc. (NASDAQ:AMD) fell 9% to $61.75 after the company lowered its sales guidance for the third quarter.
- Levi Strauss & Co (NYSE:LEVI) fell 8.8% to $14.52. Levi Strauss reported upbeat earnings for its third quarter on Thursday, but lowered its full-year profit view.
